Publications by authors named "Estefania Santos-Mazo"

Metformin, a hypoglycemic drug for Type 2 diabetes mellitus, shows variability in pharmacokinetics and response due to membrane transporters. This study followed 34 Type 2 diabetes mellitus patients on metformin treatment. Genetic variants in 11 metformin transport-related genes were analyzed, revealing associations.

View Article and Find Full Text PDF
Article Synopsis
  • Metformin is the primary treatment for type 2 diabetes, but individual responses vary significantly due to factors like age, sex, and ethnicity.
  • This study is the first to evaluate how demographic factors and various transporter polymorphisms influence metformin pharmacokinetics in healthy individuals, revealing that adjustments for dose-to-weight ratio are crucial in understanding these effects.
  • Findings indicate that multiple patient characteristics must be considered for personalized metformin treatment, as the pharmacokinetics are influenced by a combination of demographics and genetic factors, while certain polymorphisms showed no significant effect.
View Article and Find Full Text PDF

Introduction: Immune checkpoint inhibitors (ICPI) have improved progression-free survival in several solid tumors. Side effects are related to overstimulation of the immune system. Thyroid dysfunction (TD) is the most common endocrine immune-related adverse event of ICPI.

View Article and Find Full Text PDF

Non-ketotic hyperglycemia has occasionally been associated with various neurological abnormalities including movement disorders. Hyperglycemic hyperosmolar syndrome (HHS) is the second most common cause of hemiballism-hemichorea, which is due to a contralateral putaminal lesion. We describe a 95-year-old woman with HHS who developed hemichorea-hemiballism syndrome due to a putaminal lesion.

View Article and Find Full Text PDF